טוען...
Durable and sustained immune tolerance to ERT in Pompe disease with entrenched immune responses
BACKGROUND. Enzyme replacement therapy (ERT) has prolonged survival and improved clinical outcomes in patients with infantile Pompe disease (IPD), a rapidly progressive neuromuscular disorder. Yet marked interindividual variability in response to ERT, primarily attributable to the development of ant...
שמור ב:
| הוצא לאור ב: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Clinical Investigation
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4970756/ https://ncbi.nlm.nih.gov/pubmed/27493997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.86821 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|